Relief Therapeutics Reports In Vivo Data Indicating Prolong

Relief Therapeutics Holding SA / Key word(s): Study results28-March-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports In Vivo Data Publis...

Related Keywords

Lisboa , Portugal , Geneva , Genè , Switzerland , United States , Lisbon , Swiss , Paolo Galfetti , Centro Hospitalar Universit , Michael Miller , Jack Weinstein , Advita Lifescience Gmb , Relief Therapeutics Holding Sa Key , Faculty Of Medical Sciences , Pharma Research , Htm Technology , Swiss Exchange , Rx Communications Group , International Journal Of Molecular Sciences , Neurorx Inc , Relief Therapeutics Holding , Therapeutic Wholly Owned Subsidiary , Reports In Vivo Data Published , Peer Reviewed , International Journal , Molecular Sciences , Indicating Prolonged Release , Amino Acids Using Its , May Have Benefits , Release Amino Acid , Formulated With , May Have Beneficial Effects , Catabolism With , Direct Impact , Muscle Mass , Strength And , Vivo Metabolic Responses , Different Formulations , Amino Acid Mixtures , Assistant Professor , Medical Sciences , Lisbon Reference Centre , Inherited Metabolic Diseases , Hospitalar Universit , Chief Executive Officer , Vasoactive Intestinal Peptide , License Agreement , Acer Therapeutics , Urea Cycle Disorders , Maple Syrup Urine , Advita Lifescience Gmbh , Financial Officer ,